Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
British Journal of Haematology
|
June 6, 2023
Immune thrombocytopenia purpura relapse presented by Jacuzzi sign
Pierre-Edouard Debureaux, Stéphanie Harel
Journal of Hepatology
|
September 29, 2020
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis
Jean-Jacques Kiladjian, Pierre-Edouard Debureaux, Aurélie Plessier, et al.
Annals of Hematology
|
January 8, 2021
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail
Pierre-Edouard Debureaux, Mathilde Ruggiu, Stéphanie Mathis, et al.
Current Research in Translational Medicine
|
January 29, 2019
Rhino-orbital Mucormycosis presenting as facial cellulitis in a patient with high-risk acute myeloid leukemia in relapse
Pierre-Edouard Debureaux, Olivier Paccoud, Juliette Guitard, et al.
La Revue De Medecine Interne
|
August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]
Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Haematologica
|
July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndrome
Alexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Therapeutic Advances in Hematology
|
August 4, 2025
Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years
Alexis Talbot, Pierre-Edouard Debureaux, Agnès Lillo-Le Louet, et al.
British Journal of Haematology
|
April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients
Dikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Frontiers in Immunology
|
December 26, 2022
Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study
Pierre-Edouard Debureaux, Stéphanie Harel, Nathalie Parquet, et al.
Bone Marrow Transplantation
|
September 27, 2019
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
Pierre-Edouard Debureaux, Myriam Labopin, Anne-Claire Mamez, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
British Journal of Haematology
|
June 6, 2023
Immune thrombocytopenia purpura relapse presented by Jacuzzi sign
Pierre-Edouard Debureaux, Stéphanie Harel
Journal of Hepatology
|
September 29, 2020
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis
Jean-Jacques Kiladjian, Pierre-Edouard Debureaux, Aurélie Plessier, et al.
Annals of Hematology
|
January 8, 2021
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail
Pierre-Edouard Debureaux, Mathilde Ruggiu, Stéphanie Mathis, et al.
Current Research in Translational Medicine
|
January 29, 2019
Rhino-orbital Mucormycosis presenting as facial cellulitis in a patient with high-risk acute myeloid leukemia in relapse
Pierre-Edouard Debureaux, Olivier Paccoud, Juliette Guitard, et al.
La Revue De Medecine Interne
|
August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]
Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Haematologica
|
July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndrome
Alexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Therapeutic Advances in Hematology
|
August 4, 2025
Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years
Alexis Talbot, Pierre-Edouard Debureaux, Agnès Lillo-Le Louet, et al.
British Journal of Haematology
|
April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients
Dikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Frontiers in Immunology
|
December 26, 2022
Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study
Pierre-Edouard Debureaux, Stéphanie Harel, Nathalie Parquet, et al.
Bone Marrow Transplantation
|
September 27, 2019
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
Pierre-Edouard Debureaux, Myriam Labopin, Anne-Claire Mamez, et al.
Page
of 3